Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Outlook Therapeutics, Inc. (NASDAQ: OTLK)
OTLK Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-20.90%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
100.70%
OTLK Stock Analysis
OTLK
PE Ratio:
OTLK
PEG Ratio:
Not Available
OTLK
Forward EPS Growth (12 month):
0.00%
OTLK
PS Ratio:
96.7
OTLK
PSG Ratio:
Not Available
OTLK
Forward Revenue Growth (12 month):
0.00%
OTLK Articles
No data was found